[Prevention and treatment of coronary lesions in Kawasaki disease. Treatment with anti-platelet agents and aspirin: optimum dosages and their evaluation].
D000783:Aneurysm / Q000517:prevention & control*; D001241:Aspirin / Q000008:administration & dosage*; D003327:Coronary Disease / Q000517:prevention & control*; D004341:Drug Evaluation; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D009080:Mucocutaneous Lymph Node Syndrome / Q000097:blood / Q000150:complications*; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation
D005343:Fibrinolytic Agents; D001241:Aspirin